Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice
- PMID:15961704
- DOI: 10.1161/01.ATV.0000174125.89058.b6
Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice
Abstract
Objective: To elucidate processes by which the antioxidant probucol increases lesion size at the aortic sinus and decreases atherosclerosis at more distal sites in apolipoprotein E-deficient (apoE(-/-)) mice.
Methods and results: Male apoE(-/-) mice were fed high-fat chow with 1% (w/w) probucol or without (controls) for 6 months, before aortic sinus, arch, and descending aorta were analyzed separately for lesion size and composition. Compared with control, probucol significantly increased lesion size by 33% at the sinus, but it inhibited atherosclerosis at the descending aorta by 94%. Sites where atherosclerosis was inhibited contained substantially fewer macrophages, less lipids (cholesterol and cholesteryl esters), and endogenous antioxidant (alpha-tocopherol), but not oxidized lipids, and the extent to which probucol metabolism occurred was increased. Compared with control, aortic sinus lesions of probucol mice contained a substantially increased content of extracellular matrix, but decreased total cell and macrophage density, comparable levels of lipids and alpha-tocopherol, and decreased concentrations of oxidized lipids (cholesteryl ester hydroperoxides, F2-isoprostanes, and 7-ketocholesterol).
Conclusions: Probucol affects atherosclerosis in apoE(-/-) mice independent of the accumulation of arterial lipid oxidation products, thereby dissociating the 2 processes. Rather, probucol exerts antiinflammatory activity by decreasing accumulation of macrophages in lesions, and it promotes a more stable lesion composition at the aortic sinus.
Similar articles
- Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.Yoshikawa T, Shimano H, Chen Z, Ishibashi S, Yamada N.Yoshikawa T, et al.Horm Metab Res. 2001 Aug;33(8):472-9. doi: 10.1055/s-2001-16940.Horm Metab Res. 2001.PMID:11544561
- Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C.Hechler B, et al.Circulation. 2008 Aug 12;118(7):754-63. doi: 10.1161/CIRCULATIONAHA.108.788927. Epub 2008 Jul 28.Circulation. 2008.PMID:18663083
- IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.Sukhanov S, et al.Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. doi: 10.1161/ATVBAHA.107.156257. Epub 2007 Oct 4.Arterioscler Thromb Vasc Biol. 2007.PMID:17916769
- Vascular protectants for the treatment of atherosclerosis.Tardif JC, Grégoire J, Lavoie MA, L'Allier PL.Tardif JC, et al.Expert Rev Cardiovasc Ther. 2003 Sep;1(3):385-92. doi: 10.1586/14779072.1.3.385.Expert Rev Cardiovasc Ther. 2003.PMID:15030266Review.
- Clinical results with AGI-1067: a novel antioxidant vascular protectant.Tardif JC.Tardif JC.Am J Cardiol. 2003 Feb 6;91(3A):41A-49A. doi: 10.1016/s0002-9149(02)03149-1.Am J Cardiol. 2003.PMID:12645643Review.
Cited by
- Cathepsin G activity lowers plasma LDL and reduces atherosclerosis.Wang J, Sjöberg S, Tang TT, Oörni K, Wu W, Liu C, Secco B, Tia V, Sukhova GK, Fernandes C, Lesner A, Kovanen PT, Libby P, Cheng X, Shi GP.Wang J, et al.Biochim Biophys Acta. 2014 Nov;1842(11):2174-83. doi: 10.1016/j.bbadis.2014.07.026. Epub 2014 Aug 1.Biochim Biophys Acta. 2014.PMID:25092171Free PMC article.
- Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR-/- Mice.Zhu H, Jin X, Zhao J, Dong Z, Ma X, Xu F, Huang W, Liu G, Zou Y, Wang K, Hu K, Sun A, Ge J.Zhu H, et al.J Cardiovasc Pharmacol. 2015 Jun;65(6):620-7. doi: 10.1097/FJC.0000000000000234.J Cardiovasc Pharmacol. 2015.PMID:25714599Free PMC article.
- Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation.Goodman CA, Horvath D, Stathis C, Mori T, Croft K, Murphy RM, Hayes A.Goodman CA, et al.J Appl Physiol (1985). 2009 Jul;107(1):144-54. doi: 10.1152/japplphysiol.00040.2009. Epub 2009 May 7.J Appl Physiol (1985). 2009.PMID:19423840Free PMC article.
- The Combination Treatment of Curcumin and Probucol Protects Chondrocytes from TNF-α Induced Inflammation by Enhancing Autophagy and Reducing Apoptosis via the PI3K-Akt-mTOR Pathway.Han G, Zhang Y, Li H.Han G, et al.Oxid Med Cell Longev. 2021 Jun 24;2021:5558066. doi: 10.1155/2021/5558066. eCollection 2021.Oxid Med Cell Longev. 2021.PMID:34257809Free PMC article.
- A Timing Effect of 17-β Estradiol on Atherosclerotic Lesion Development in Female ApoE-/- Mice.Ebenebe OV, Ashley Z, Erickson JR, Heather AK.Ebenebe OV, et al.Int J Mol Sci. 2020 Jul 1;21(13):4710. doi: 10.3390/ijms21134710.Int J Mol Sci. 2020.PMID:32630298Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous